1 March 2024 in Psychiatry (Moscow) (Psikhiatriya)
Background: schizophrenia is a severe mental illness characterized not only by cognitive but also sensory impairments, including the visual system. Research suggests impairments in contrast processing in schizophrenia, but evidence regarding the nature of these impairments is inconsistent. The theory of tremor modulation signal connects contrast sensitivity with the parameters of ocular microtremor – high-frequency and low-amplitude micromovements that are controlled by neurons of the nuclei of the brain stem. The parameters of ocular microtremor in psychopathology, in particular in schizophrenia, have not been described in the scientific literature.The aim of the study was to study the characteristics of contrast sensitivity and microtremor of the eyes of patients with schizophrenia.Patients and methods: to register contrast sensitivity, the method of computer visocontrastometry was used. Gabor elements were presented with spatial frequencies of 0.4, 1.0, 3.0, and 10 cycles/deg. Eye microtremor was recorded using a non-contact high-speed video recording method using an original optical system. The study involved 30 patients diagnosed as paranoid schizophrenia and 30 people without psychopathology and neurological diseases.Results: the contrast sensitivity of patients was reduced in the region of medium and high spatial frequencies compared with conditionally healthy controls, which may be associated with the chronic course of the disease. Ocular microtremor in the patient group was characterized by a lower frequency and a higher amplitude compared to the control group.Conclusions: contrast sensitivity and ocular microtremor are considered as potential markers for determining the functional state in schizophrenia, which requires further research and accumulation of experimental data.
30 December 2025 in S.S. Korsakov Journal of Neurology and Psychiatry
Objective. To evaluate ocular microtremor (OMT) and contrast sensitivity (CS) as potential neurophysiological markers of schizophrenia spectrum disorders (SSD). Material and methods. The study included 85 patients diagnosed with paranoid schizophrenia (F20.0), schizotypal (F21), and schizoaffective disorder (F25.X), as well as 29 healthy volunteers. The CS assessment was performed using an adaptive staircase procedure, and the OMT recording was conducted via video recording. Psychometric methods included the PANSS (Positive and Negative Syndrome Scale) and the Simpson-Angus Scale (SAS) for extrapyramidal symptoms. Results. Patients with SSD showed a decrease in CS at spatial frequencies of 1.0 and 10 cycles/deg, as well as a decrease in OMT frequency and an increase in OMT amplitude, compared with healthy subjects (p<0.05). These differences persisted even in patients without receiving long-term antipsychotics compared with healthy subjects. Conclusion. Considering the data obtained, the parameters of OMT and CS seem to be promising in the context of the search for neurophysiological markers of schizophrenia.
21 March 2026 in Psychiatry (Moscow) (Psikhiatriya)
Background: oculomotor dysfunction is one of the most stable markers of schizophrenia. At the same time, the attention of researchers is mainly focused on the characteristics of macro eye movements in nervous and mental disorders, while the features of micro eye movements, in particular ocular microtremor (OMT) generated by the oscillators of the brainstem and cerebellum, poorly understood. The aim was to study the potential of OMT as a marker for objective assessment of changes in the functional state of patients with schizophrenia spectrum disorders. Patients, Participants and Methods: the study involved 30 healthy subjects, 47 patients with paranoid schizophrenia, 27 patients with schizotypal disorder and 20 patients with schizoaffective disorder. Instrumental recording of OMT was performed using the super–slow motion video recording method. Average values of OMT frequency and amplitude were calculated, as well as the frequency of OMT frequency values falling within the intervals of 0–40 Hz, 40–50 Hz, 50–60 Hz, 60–70 Hz, 70–100 Hz, 100–110 Hz and the average OMT amplitude in each frequency range. Results: patients differed from the healthy control group by a decrease in the high–frequency component (70–110 Hz) in the OMT spectrum with a simultaneous increase in the proportion of the low–frequency component (40–60 Hz). Intragroup comparison of OMT frequency indicators at the time of inclusion in the study and showed that significant changes were observed only in the group of patients with schizophrenia in the average OMT frequency and in the frequency of OMT frequency falling within the ranges of 60–70 Hz and 70–100 Hz after 8 weeks of antipsychotic therapy. Significant changes in the OMT amplitude during therapy were also observed only in the group of patients with schizophrenia and in the low–frequency component of the OMT. The average values of the OMT amplitude were higher in the groups of patients, regardless of their condition, compared with the values of the OMT amplitude in the healthy control. Conclusion: the potential of using OMT recording to assess the dynamics of the functional state in schizophrenia spectrum disorders can carry important, missing information about the neurophysiological mechanisms of the disease and serve as a tool for differential diagnosis and assessment of the dynamics of the condition.